The Global Ophthalmoplegia Market report offers all the company profiles of the leading players and brands. The Global Ophthalmoplegia Market is divided into products, applications, end users and regions. The drivers and restrictions of the market have been explained with the help of the SWOT analysis and the Porter Five Forces tool. Global Ophthalmoplegia Market report is an in-depth study of the Optic Devices industry that explains the definition of the market, classifications, applications, commitments and global industry trends. The analysis of the historical year and the base year 2017 in 2016 shows that new highs will be achieved in the 2018-2025. Global Ophthalmoplegia Market. The best players and brands on the market make calculated movements such as product launches, research, joint ventures, mergers and acquisitions. This report gives the opportunity not only to compete but to surpass the competition.
Global Ophthalmoplegia Market According to Data Bridge Market Research new Market report – Industry Trends and Forecast is expected to grow at a CAGR of 7.5% during the forecast period of 2018 to 2025.
Major Players: Global Ophthalmoplegia Market
Some of the major players operating in the global Ophthalmoplegia market are- Abbott, Novartis AG, ZEISS International, Valeant, Amritt, Inc., Medline Industries Inc., ALLERGAN, Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd, Valeant, Santen Pharmaceutical Co., Ltd., TOPCON CORPORATION, NIDEK CO., LTD, HOYA Corporation, Essilor.
The sample report is instantly available at @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-ophthalmoplegia-market
Global Ophthalmoplegia Market
Ophthalmoplegia is an eye disorder in which one or more of the six muscles of the eye got affected and thus causing it to weakness of the eye muscles which ultimately leads to eye paralysis. This disorder can be congenital or also can be developed later in life. Few common causes include brain tumor, migraine, thyroid disease, stroke, infection in the eye and any kind of brain injuries.
In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged. Multiple devices and treatement are available in the market which can cure or improve the eyesight of the patients.. As there is increase in geriatric polulation as well as increasing cases of opthalmoplegia the global ophthalmoplegia market is showing a vast growth. .
According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80 % people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries..
Sparing of the pupil with paralysis of the third cranial nerve has been reported to be characteristic of diabetic ophthalmoplegia. In a large series of oculomotor paralyses, 18 out of 20 diabetic patients showed sparing of the pupil. The one histopathologic study of diabetic third nerve paralysis suggested that the normal pupillary reactions were due to sparing of the circumferential portion of the third nerve.
A retrospective study of all diabetic patients with ophthalmoplegia who were seen in the Metabolic Division at “S. Biagio” Hospital, Marsala, was conducted over the 10 year period from 1998 to 2007.
A detailed history and blood laboratory reports were obtained for each patient.
During the survey a total of 6,765 diabetic subjects were hospitalised and ophthalmoplegia was identified in 27 patients (0.40%).
Isolated nerve palsies accounted for the majority of patients (59.3%), with nerve palsies (29.6%) occurring more frequently than multiple palsies (11.1%).
Global Ophthalmoplegia Market
The global market for ophthalmoplegia by the following sub-categories is presented
By Product Type (External Opthalmoplegia, Internuclear Opthalmoplegia), By Treatment (Surgery, Drug Treatment), By End User (Hospitals, Clinics, Ambulatory Centeres), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Report Can Be Provided as per Organization Requirement at @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ophthalmoplegia-market
FACTORS DRIVING GROWTH IN THE GLOBAL OPTHALMOPLEGIA MARKET
Rising number of diseases including strokes, thyroid disease, and brain tumor:
From multiple studies it was found that the incidence of the brain tumors are increasing.. Brain tumors diagnosed in the period 1985-2005 were identified through the Tuscan Cancer Registry, a population-based registry active since 1985 in the area of Florence and Prato. Age-standardized incidence rates and average annual percent change (APC) was calculated for the entire period from 1985 to 2005 for sex and behavior.
A total of 4,417 brain tumors was registered, 1,900 (43.0%) in male and 2,517 (57.0%) in female patients. Malignant and benign tumor incidence rates were 8.3 and 4.1, respectively, among males and 6.4 and 7.2, respectively, among females.
National Research Council in Washington, the Karolinska Institute in Stockholm and other institutions recently compared mortality figures from about 1968 to 1987 for the United States, Britain, Italy, France, West Germany and Japan. They found that among people 65 and older, deaths from brain tumors rose in all nations at up to 200% for the period.
Increasing prevalence of eye sight affecting diseases:
According to the new report Issued by the WHO it was found that many of them potentially causing severe vision loss or blindness — are on the rise in the Most dramatic is the rise in Diabetic Retinopathy. Another vision problem, age-related macular degeneration, is up substantially, with a 25.0% increase. More than 2 million age 50 and older are affected now.
Diabetic retinopathy and age-related eye diseases (e.g., cataracts, macular degeneration, and glaucoma) are the major cause for visual impairment and blindness. Diabetes affects approximately 18 million U.S. adults, of whom an estimated 30% have undiagnosed diabetes, and imposes an increased risk for eye disease. To characterize the prevalence of visual impairment and selected eye diseases among persons aged >50 years with and without diabetes, CDC analyzed data from the 2002 National Health Interview Survey (NHIS).
TOC is available at @ https://databridgemarketresearch.com/toc/?dbmr=global-ophthalmoplegia-market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Email: [email protected]